HistoRx, Inc. announced today the expansion of its senior management team in order to advance the development and commercialization of the Company’s first series of molecular diagnostic tests based on the AQUA(TM) platform. HistoRx has added three new industry leaders with extensive experience in the production and commercialization of protein biomarker discovery and diagnostic products. The new additions represent a significant increase in the company’s effort to advance personalized medicine by stratifying patients and tailoring therapeutic regimes through improved predictive diagnostics.
